Express Scripts to provide patients with faster path to rare disease diagnosis and treatment

Express Scripts announced Thursday a new Rare Conditions Care Value (RCCV) program with the introduction of the Second Opinion support service in partnership with PinnacleCare, a private health advisory firm.

Express Scripts announced Thursday a new Rare Conditions Care Value (RCCV) program with the introduction of the Second Opinion support service in partnership with PinnacleCare, a private health advisory firm. Members whose plan enrolls in the new program will have free access to Second Opinion, which offers a second opinion from a leading specialist in the field. The support service addresses the issues that patients with rare diseases must deal with in obtaining a diagnosis and treatment. "The years spent going to different doctors, getting myriad medical tests, managing paperwork, and experimenting with numerous treatments is an ordeal for patients and their health, as well as for those who love and care for them," noted Glen Stettin, MD, senior vice president of clinical, research and new solutions at Express Scripts. "Getting to the right diagnosis and the right therapy is critically important for the more than 30 million Americans currently with a rare disease." Express Scripts noted that among patients who have used PinnacleCare services, nearly 77% of engagements have resulted in a change of diagnosis, treatment, or care, when working in coordination with a patient's PBM and medical benefit plan.